CD4 and neoplasm: The high ratio of Foxp3+ Tregs to CD4+ effector Tcells in subcutaneous tumours may explain why they are refractory to PD-1 blockade.Conversely, the reduced fraction of Tregs in orthotopic tumours may explain theminimal response to CTLA-4 blockade.